| DFSVX | FCPVX | DFSVX / FCPVX | |
| Total Expense Ratio | 0.31 | 0.91 | 34% |
| Annual Report Gross Expense Ratio | 0.31 | 0.91 | 34% |
| Fund Existence | 33 years | 21 years | - |
| Gain YTD | 5.380 | 0.007 | 72,830% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 16.4B | 4.58B | 358% |
| Annual Yield % from dividends | 1.66 | 0.84 | 197% |
| Returns for 1 year | 6.42 | -0.89 | -718% |
| Returns for 3 years | 28.72 | 18.27 | 157% |
| Returns for 5 years | 82.73 | 49.04 | 169% |
| Returns for 10 years | 64.27 | 21.08 | 305% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PWDCX | 10.33 | 0.09 | +0.88% |
| Donoghue Forlines Dividend C | |||
| MCECX | 16.09 | 0.14 | +0.88% |
| ClearBridge Emerging Markets C | |||
| ACIHX | 71.41 | 0.61 | +0.86% |
| American Century Growth G | |||
| FTDZX | 169.55 | 0.80 | +0.47% |
| Franklin Biotechnology Discovery Adv | |||
| HFYTX | 13.44 | 0.05 | +0.37% |
| Hartford Schroders Intl Multi-Cp Val R5 | |||